Frontier Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.44M | Sell |
|
|||||
|
2022
Q2 | $2.85M | Sell |
|
|||||
|
2022
Q1 | $9.43M | Sell |
|
|||||
|
2021
Q4 | $10.8M | Buy |
|
|||||
|
2021
Q3 | $6.42M | Sell |
|
|||||
|
2021
Q2 | $15.4M | Buy |
|
|||||
|
2021
Q1 | $12.9M | Sell |
|
|||||
|
2020
Q4 | $48.4M | Sell |
|
|||||
|
2020
Q3 | $54.1M | Buy |
|
|||||
|
2020
Q2 | $52.9M | Buy |
|
|||||
|
2020
Q1 | $35.3M | Buy |
|
|||||
|
2019
Q4 | $19.5M | Sell |
|
|||||
|
2019
Q3 | $17.1M | Buy |
|
|||||
|
2019
Q2 | $4.09M | Sell |
|
|||||
|
2019
Q1 | $3.99M | Buy |
|
|||||
|
2018
Q4 | $1.55M | Sell |
|
|||||
|
2018
Q3 | $3.48M | Sell |
|
|||||
|
2018
Q2 | $5.22M | Buy |
|